Edgewise Therapeutics Stock Forecast
NASDAQ: EWTXHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
EWTX analyst consensus
Consensus (13 analysts)
buy
Avg. price target
$52.62+34.13%
- Strong buy 3
- Buy 8
- Hold 2
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 13 Wall Street analysts covering Edgewise Therapeutics (2026-10-09), 11 rate the stock a buy or strong buy, 2 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $52.62, with a high estimate of $66.00 and a low estimate of $36.00. The average target implies upside of 34.1% from the current price of $39.23.
The spread between the highest and lowest targets is 83.3%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for EWTX.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 3 | 23% |
| Buy | 8 | 62% |
| Hold | 2 | 15% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-09.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $36.00 | -8.23% |
| Average target | $52.62 | +34.13% |
| High target | $66.00 | +68.24% |